Dechra

Dechra, a UK-based Pharmaceutical Preparation Manufacturing company, reported total carbon emissions of approximately 146,266 tonnes CO2e in 2022. This includes about 7,596 tonnes CO2e from Scope 1 emissions, 4,896 tonnes CO2e from Scope 2 emissions (market-based), and 132,504 tonnes CO2e from Scope 3 emissions.

The company has set ambitious climate commitments, with Science Based Targets initiative (SBTi) validated targets. Dechra aims to achieve net-zero greenhouse gas emissions across its entire value chain by no later than 2050.

Near-term targets include reducing absolute Scope 1 and 2 GHG emissions by 42% by 2030, using a 2021 base year. Additionally, Dechra is committed to reducing Scope 3 GHG emissions by 51.6% per GBP value added within the same timeframe.

For long-term goals, Dechra plans to reduce absolute Scope 1 and 2 GHG emissions by 90% by 2050 from a 2021 base year, and Scope 3 GHG emissions by 97% per GBP value added within the same timeframe. These targets reflect a commitment to a 1.5°C trajectory for its operational emissions.

In 2021, Dechra's total carbon emissions were approximately 168,350 tonnes CO2e, comprising about 10,221 tonnes CO2e from Scope 1, 5,261 tonnes CO2e from Scope 2 (market-based), and 151,375 tonnes CO2e from Scope 3. In 2020, total emissions were around 14,063 tonnes CO2e, with Scope 1 at approximately 6,747 tonnes CO2e, Scope 2 at 4,969 tonnes CO2e, and Scope 3 at 2,347 tonnes CO2e.